[Developments in the field of antiviral vaccinations].
D000328:Adult; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D002648:Child; D004673:Encephalomyelitis, Acute Disseminated / Q000209:etiology; D005260:Female; D005827:Genetics, Microbial; D006801:Humans; D007252:Influenza Vaccines / Q000009:adverse effects; D008458:Measles Vaccine / Q000009:adverse effects; D009108:Mumps Vaccine / Q000009:adverse effects; D010998:Pleurisy / Q000209:etiology; D011014:Pneumonia / Q000209:etiology; D011055:Poliovirus Vaccine, Oral / Q000009:adverse effects; D011819:Rabies Vaccines / Q000009:adverse effects; D012409:Rubella / Q000276:immunology; D012411:Rubella Vaccine / Q000009:adverse effects; D012900:Smallpox Vaccine / Q000009:adverse effects; D014611:Vaccination / Q000009:adverse effects*; D014765:Viral Vaccines / Q000009:adverse effects* / Q000145:classification; D014777:Virus Diseases / Q000276:immunology*
D000906:Antibodies; D007252:Influenza Vaccines; D008458:Measles Vaccine; D009108:Mumps Vaccine; D011055:Poliovirus Vaccine, Oral; D011819:Rabies Vaccines; D012411:Rubella Vaccine; D012900:Smallpox Vaccine; D014765:Viral Vaccines
Entwicklungen auf dem Gebiet antiviraler Impfungen.